Clinical trials
Not yet recruiting Phase 3 Carcinoma, Hepatocellular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tongji Hospital | 3 |
| BeOne Medicines | 1 |
| Changchun GeneScience Pharmaceutical Co., Ltd. | 1 |
| Shanghai Henlius Biotech | 1 |
| Shanghai Junshi Bioscience Co., Ltd. | 1 |
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 1 |
| Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 1 |
| Tempest Therapeutics | 1 |
| University of Geneva, Switzerland | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 11 |
| Liver Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Cachexia | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.